Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TriSalus Life Sciences (TLSI) Change in Inventory (2022 - 2025)

Historic Change in Inventory for TriSalus Life Sciences (TLSI) over the last 4 years, with Q3 2025 value amounting to -$531000.0.

  • TriSalus Life Sciences' Change in Inventory fell 19550.36% to -$531000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$724000.0, marking a year-over-year decrease of 13054.85%. This contributed to the annual value of $1.5 million for FY2024, which is 4007.46% up from last year.
  • As of Q3 2025, TriSalus Life Sciences' Change in Inventory stood at -$531000.0, which was down 19550.36% from -$355000.0 recorded in Q2 2025.
  • In the past 5 years, TriSalus Life Sciences' Change in Inventory ranged from a high of $915000.0 in Q4 2023 and a low of -$531000.0 during Q3 2025
  • Its 4-year average for Change in Inventory is $165750.0, with a median of $149500.0 in 2022.
  • As far as peak fluctuations go, TriSalus Life Sciences' Change in Inventory surged by 41962.62% in 2024, and later tumbled by 19550.36% in 2025.
  • TriSalus Life Sciences' Change in Inventory (Quarter) stood at $185000.0 in 2022, then surged by 394.59% to $915000.0 in 2023, then crashed by 94.75% to $48000.0 in 2024, then tumbled by 1206.25% to -$531000.0 in 2025.
  • Its Change in Inventory was -$531000.0 in Q3 2025, compared to -$355000.0 in Q2 2025 and $114000.0 in Q1 2025.